TABLE 50Sensitivity analysis for a starting age of 40 years: breast-conserving model

RegimenCost (£)QALYICER (£)Net benefits (£)
λ = £20,000Rankλ = £30,000Rank
12-month interval
No surveillance509714.592286,74213432,66113
Mammography alone11,88516.3643831315,3921479,0313
Mammography + clinical13,33216.42822,596315,2262479,5052
MRI + clinical16,38916.54027,173314,4193479,8231
18-month interval
No surveillance509714.592286,74213432,66113
Mammography alone11,30816.1833904312,3487474,1757
Mammography + clinical12,45716.27212,929312,9765475,6926
MRI + clinical14,85016.43714,459313,8934478,2654
24-month interval
No surveillance509714.592286,74213432,66113
Mammography alone10,82916.0194016309,55810469,75110
Mammography + clinical11,85316.1249769310,6309471,8719
MRI + clinical13,96616.32810,350312,6006475,8835
36-month interval
No surveillance509714.592286,74213432,66113
Mammography alone10,40415.8754135307,10012465,85212
Mammography + clinical11,36315.9898414308,42211468,31411
MRI + clinical13,33716.2198573311,0538473,2488

From: 7, Economic evaluation

Cover of The Clinical Effectiveness and Cost-Effectiveness of Different Surveillance Mammography Regimens After the Treatment for Primary Breast Cancer: Systematic Reviews, Registry Database Analyses and Economic Evaluation
The Clinical Effectiveness and Cost-Effectiveness of Different Surveillance Mammography Regimens After the Treatment for Primary Breast Cancer: Systematic Reviews, Registry Database Analyses and Economic Evaluation.
Health Technology Assessment, No. 15.34.
Robertson C, Arcot Ragupathy SK, Boachie C, et al.
Southampton (UK): NIHR Journals Library; 2011 Sep.
© 2011, Crown Copyright.

Included under terms of UK Non-commercial Government License.

PubMed Health. A service of the National Library of Medicine, National Institutes of Health.